Samsung Bioepis CH GmbH - Byooviz 10 mg / mL, Injektionslösung in Durchstechflasche Swissmedic Registration 68690 Sequence 01 Product name Byooviz 10 mg / mL Description Injektionslösung in Durchstechflasche ATC-Classification S01LA04 ATC-Description Ranibizumab Introduction of Sequence 13.07.2022
Composition ranibizumabum 10 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml. Packungsbestandteile Galenic Form Injection solution Excipiens Active Agent Dose Ranibizumab 10 mg/ml
BAG: Active Agent Dose Ranibizumab 2.3 mg
Inactive agents Histidin Hydrochloride Monohydrate Histidine
